Brandon Webb

4.0k total citations
64 papers, 1.4k citations indexed

About

Brandon Webb is a scholar working on Epidemiology, Infectious Diseases and Applied Microbiology and Biotechnology. According to data from OpenAlex, Brandon Webb has authored 64 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 37 papers in Infectious Diseases and 12 papers in Applied Microbiology and Biotechnology. Recurrent topics in Brandon Webb's work include Pneumonia and Respiratory Infections (18 papers), COVID-19 Clinical Research Studies (12 papers) and Antibiotic Use and Resistance (12 papers). Brandon Webb is often cited by papers focused on Pneumonia and Respiratory Infections (18 papers), COVID-19 Clinical Research Studies (12 papers) and Antibiotic Use and Resistance (12 papers). Brandon Webb collaborates with scholars based in United States, Argentina and United Kingdom. Brandon Webb's co-authors include Nathan C. Dean, Daanish Hoda, Edward Stenehjem, Clyde D. Ford, Bert K. Lopansri, Samuel M. Brown, Maria Teresa Seville, Andrew S. Chung, Michaela A. Gazdik and Jeffrey P. Ferraro and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Brandon Webb

63 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brandon Webb United States 20 781 681 257 206 179 64 1.4k
Fainareti N. Zervou United States 22 1.2k 1.6× 860 1.3× 221 0.9× 128 0.6× 133 0.7× 46 1.7k
Kyungmin Huh South Korea 24 945 1.2× 621 0.9× 145 0.6× 180 0.9× 130 0.7× 152 2.0k
Ioannis M. Zacharioudakis United States 23 1.3k 1.7× 927 1.4× 235 0.9× 143 0.7× 265 1.5× 60 1.9k
Stefan Hagel Germany 22 691 0.9× 753 1.1× 145 0.6× 209 1.0× 190 1.1× 125 1.9k
Natasha N. Pettit United States 21 607 0.8× 863 1.3× 193 0.8× 159 0.8× 59 0.3× 66 1.6k
Julien Poissy France 21 1.4k 1.8× 645 0.9× 180 0.7× 110 0.5× 154 0.9× 72 2.2k
Luis Felipe Reyes Colombia 26 831 1.1× 849 1.2× 256 1.0× 114 0.6× 253 1.4× 107 2.0k
Rafael Zaragoza Spain 26 1.2k 1.5× 1.4k 2.1× 408 1.6× 331 1.6× 103 0.6× 107 2.3k
Edward Stenehjem United States 20 583 0.7× 365 0.5× 167 0.6× 474 2.3× 97 0.5× 72 1.3k
José Bordón United States 24 376 0.5× 1.3k 1.9× 196 0.8× 147 0.7× 161 0.9× 69 2.1k

Countries citing papers authored by Brandon Webb

Since Specialization
Citations

This map shows the geographic impact of Brandon Webb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandon Webb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandon Webb more than expected).

Fields of papers citing papers by Brandon Webb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brandon Webb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandon Webb. The network helps show where Brandon Webb may publish in the future.

Co-authorship network of co-authors of Brandon Webb

This figure shows the co-authorship network connecting the top 25 collaborators of Brandon Webb. A scholar is included among the top collaborators of Brandon Webb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brandon Webb. Brandon Webb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olson, Jared, Adam L. Hersh, C. Dustin Waters, et al.. (2025). Interventions to optimize duration of antibiotic therapy and encourage oral transition for uncomplicated gram-negative blood stream infections across a health system. Infection Control and Hospital Epidemiology. 47(2). 180–188.
2.
Aggarwal, Neil R., Laurel Beaty, Tellen D. Bennett, et al.. (2024). Real-world use of nirmatrelvir-ritonavir in COVID-19 outpatients during BQ.1, BQ.1.1., and XBB.1.5 predominant omicron variants in three U.S. health systems: a retrospective cohort study. The Lancet Regional Health - Americas. 31. 100693–100693. 3 indexed citations
3.
Stenehjem, Edward, Brandon Webb, Catherine L. Hough, et al.. (2023). Concordance Between Initial Presumptive and Final Adjudicated Diagnoses of Infection Among Patients Meeting Sepsis-3 Criteria in the Emergency Department. Clinical Infectious Diseases. 76(12). 2047–2055. 14 indexed citations
4.
Webb, Brandon, et al.. (2023). Effect of tele‐COVID rounds and a tele‐stewardship intervention on antibiotic use in COVID‐19 patients admitted to 17 small community hospitals. Journal of Hospital Medicine. 18(8). 719–723. 2 indexed citations
5.
Horne, Benjamin D., Joseph Bledsoe, Joseph B. Muhlestein, et al.. (2022). Association of the Intermountain Risk Score with major adverse health events in patients positive for COVID-19: an observational evaluation of a US cohort. BMJ Open. 12(3). e053864–e053864. 1 indexed citations
6.
Dean, Nathan C., Brandon Webb, Allison Butler, et al.. (2022). A Pragmatic, Stepped-Wedge, Cluster-controlled Clinical Trial of Real-Time Pneumonia Clinical Decision Support. American Journal of Respiratory and Critical Care Medicine. 205(11). 1330–1336. 12 indexed citations
7.
Peltan, Ithan D., et al.. (2022). Remote Biometric Monitoring of Patients With COVID-19 With Exertional Hypoxia Treated With Supplemental Oxygen. CHEST Journal. 163(3). 498–501. 3 indexed citations
8.
Webb, Brandon, Whitney R. Buckel, Todd J. Vento, et al.. (2021). Real-world Effectiveness and Tolerability of Monoclonal Antibody Therapy for Ambulatory Patients With Early COVID-19. Open Forum Infectious Diseases. 8(7). ofab331–ofab331. 36 indexed citations
9.
Foster, Rachel, et al.. (2021). Interventions to optimize antimicrobial stewardship. SHILAP Revista de lepidopterología. 1(1). e46–e46. 16 indexed citations
10.
Peltan, Ithan D., et al.. (2021). Evaluation of potential COVID-19 recurrence in patients with late repeat positive SARS-CoV-2 testing. PLoS ONE. 16(5). e0251214–e0251214. 17 indexed citations
11.
Brown, Samuel M., Ithan D. Peltan, Lindsay Leither, et al.. (2020). Hydroxychloroquine versus Azithromycin for Hospitalized Patients with COVID-19. Results of a Randomized, Active Comparator Trial. Annals of the American Thoracic Society. 18(4). 590–597. 20 indexed citations
12.
Brown, Samuel M., Ithan D. Peltan, Brandon Webb, et al.. (2020). Hydroxychloroquine versus Azithromycin for Hospitalized Patients with Suspected or Confirmed COVID-19 (HAHPS). Protocol for a Pragmatic, Open-Label, Active Comparator Trial. Annals of the American Thoracic Society. 17(8). 1008–1015. 21 indexed citations
13.
Webb, Brandon, Ithan D. Peltan, Paul N. Jensen, et al.. (2020). Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study. The Lancet Rheumatology. 2(12). e754–e763. 214 indexed citations
14.
Ford, Clyde D., Bert K. Lopansri, Brandon Webb, et al.. (2018). Clostridioides difficile colonization and infection in patients with newly diagnosed acute leukemia: Incidence, risk factors, and patient outcomes. American Journal of Infection Control. 47(4). 394–399. 13 indexed citations
15.
Webb, Brandon, Michaela A. Gazdik, Bert K. Lopansri, et al.. (2017). Prediction of Bloodstream Infection Due to Vancomycin-Resistant Enterococcus in Patients Undergoing Leukemia Induction or Hematopoietic Stem-Cell Transplantation. Clinical Infectious Diseases. 64(12). 1753–1759. 35 indexed citations
16.
Ford, Clyde D., Michaela A. Gazdik, Bert K. Lopansri, et al.. (2016). Vancomycin-Resistant Enterococcus Colonization and Bacteremia and Hematopoietic Stem Cell Transplantation Outcomes. Biology of Blood and Marrow Transplantation. 23(2). 340–346. 33 indexed citations
17.
Webb, Brandon, Barbara Jones, & Nathan C. Dean. (2016). Empiric antibiotic selection and risk prediction of drug-resistant pathogens in community-onset pneumonia. Current Opinion in Infectious Diseases. 29(2). 167–177. 14 indexed citations
18.
Ford, Clyde D., Bert K. Lopansri, Michaela A. Gazdik, et al.. (2015). The clinical impact of vancomycin‐resistant E nterococcus colonization and bloodstream infection in patients undergoing autologous transplantation. Transplant Infectious Disease. 17(5). 688–694. 14 indexed citations
19.
Webb, Brandon, Kristin Dascomb, Edward Stenehjem, & Nathan C. Dean. (2014). Predicting risk of drug-resistant organisms in pneumonia: Moving beyond the HCAP model. Respiratory Medicine. 109(1). 1–10. 44 indexed citations
20.
Chung, Andrew S., et al.. (2013). Predictive Value of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Swab PCR Assay for MRSA Pneumonia. Antimicrobial Agents and Chemotherapy. 58(2). 859–864. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026